Buy-outs of Israeli medical innovators are regular events and recognise Israel’s success. This time, Florida-based Opko Health is buying Israel’s FineTech Pharmaceuticals – which develops “polymorphs” – different methods to deliver drugs without infringing patents.
http://www.israelnationalnews.com/News/News.aspx/151124#.TvoksNTOzi4
Another Israeli biotech is taken over
This entry was posted in Economy & Business. Bookmark the permalink.